Impact of the COVID-19 pandemic on transgender and gender diverse health care
- 24 September 2021
- journal article
- editorial
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 9 (11) , 729-731
Abstract
No abstract availableFunding Information
- BUSM
- National Institutes of Health
- National Institute on Drug Abuse (K23DA043418-04)
- National Heart, Lung, and Blood Institute (1K01HL151902-01A1)
- American Heart Association
- AHA (20CDA35320148)
This publication has 6 references indexed in Scilit:
- Gender-affirming care, mental health, and economic stability in the time of COVID-19: A multi-national, cross-sectional study of transgender and nonbinary peoplePLOS ONE, 2021
- Telemedicine and Medical Licensure — Potential Paths for ReformNew England Journal of Medicine, 2021
- Residual clinical damage after COVID-19: A retrospective and prospective observational cohort studyPLOS ONE, 2020
- Health care and mental health challenges for transgender individuals during the COVID-19 pandemicThe Lancet Diabetes & Endocrinology, 2020
- “You Have to Wait a Little Longer”: Transgender (Mental) Health at Risk as a Consequence of Deferring Gender-Affirming Treatments During COVID-19Archives of Sexual Behavior, 2020
- Development of the Gender Minority Stress and Resilience Measure.Psychology of Sexual Orientation and Gender Diversity, 2015